Precigen doses first patients with UltraCAR-T cells
Precigen said that the first patients in two phase I clinical trials have been treated with UltraCAR-T cells manufactured by its UltraPorator system.
LifeEdit Therapeutics joins ElevateBio's gene editing portfolio
Cell and gene therapy accelerator ElevateBio has added LifeEdit Therapeutics to the company's portfolio of therapeutic, technology, and manufacturing firms.
Cytiva helps Clover scale up biomanufacturing of COVID-19 vaccine
Clover Biopharmaceuticals is working with Cytiva to scale up the company's COVID-19 vaccine manufacturing capabilities.
FDA issues IND application to Dicerna, Lilly for RNAi candidate
Dicerna Pharmaceuticals' investigational new drug (IND) application for LY3561774, an RNA interference (RNAi) therapeutic, has been accepted by the U.S. Food and Drug Administration (FDA).
Bone Therapeutics acquires Catalent cell therapy manufacturer
Catalent Pharma Solutions has completed the acquisition of Bone Therapeutics' manufacturing subsidiary, Skeletal Cell Therapy Support.
EMA recommends approval of Roche's mAb breast cancer product
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use has recommended the approval of Roche's Phesgo, a fixed-dose combination of the monoclonal antibodies (mAbs) pertuzumab (Perjeta) and trastuzumab (Herceptin) with hyaluronidase.
DIANT licenses continuous manufacturing tech
The University of Connecticut has licensed its continuous manufacturing technology for pharmaceutical nanoparticles to DIANT Pharma.
UCB expands gene therapy capabilities
UCB has acquired Belgium-based Handl Therapeutics and formed a new collaboration with Florida-based Lacerta Therapeutics to accelerate the company's gene therapy activities.
Proteintech, HebeCell to develop cancer immunotherapies
Proteintech and HebeCell have announced a partnership to develop nanobody-based chimeric antigen receptors for cancer cellular immunotherapy use.
WuXi increases GMP plasmid DNA services
WuXi Advanced Therapies has expanded its cell and gene therapy platforms with capabilities to provide high-quality and cost-effective good manufacturing practice (GMP) plasmids.
Festival of Genomics & Biodata
January 28-29, 2021
London, Greater London United Kingdom
Lab of the Future USA
May 11-12, 2021
Boston, Massachusetts United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter